The pathophysiology of IgA nephropathy.
By Hitoshi Suzuki, K. Kiryluk, J. Novak, Z. Moldoveanu, A. Herr, M. Renfrow, R. Wyatt, F. Scolari, J. Mestecky, A. Gharavi and 1 more. Journal of the American Society of Nephrology, 2011
809 citations recorded by the source corpus.
Subfields: Hematology, Nephrology
View Paper: https://www.semanticscholar.org/paper/c4b4fae6123f01ae9de66ec2ba22767530e8ed95
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Watts
- L. Guillevin
- M. Cid
- N. Rasmussen
- P. Bacon
- D. Jayne
- P. Merkel
- U. Specks
Citations in the corpus
- 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. (2013, background): “In patients with either systemic IgAV or renal-limited IgA nephropathy (IgAN), IgA1 in serum and in tissue deposits has reduced terminal glycosylation in the hinge region (13).”